Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Palonosetron Aprepitant

Aprepitant had no clinically relevant effect on the pharmacokinetics of dolasetron, granisetron, ondansetron or palonosetron. [Pg.1259]

Aprepitant 125 mg on day one, then 80 mg on days 2 and 3 had no effect on the pharmacokinetics of a single 250-microgram intravenous dose of palonosetron given to healthy subjects on day one. ... [Pg.1259]

No important pharmacokinetic interactions occur, therefore no dosage adjustment is required when aprepitant is given with dolasetron, ondansetron, granisetron or palonosetron. [Pg.1259]

Shah AK, Hunt TL, Gallagher SC, Cullen MT. Pharmacokinetics of palonosetron in combination with aprepitant in healthy volunteers. CurrMedRes Opin (2005) 21, 595-601. [Pg.1260]

See other pages where Palonosetron Aprepitant is mentioned: [Pg.315]    [Pg.393]    [Pg.544]   
See also in sourсe #XX -- [ Pg.1259 ]



SEARCH



Aprepitant

Palonosetron

© 2024 chempedia.info